Geode Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38,820
| Closed | -$22.5K | – | 4844 |
|
|
2023
Q1 | $22.5K | Hold |
38,820
| – | – | ﹤0.01% | 4684 |
|
|
2022
Q4 | $27K | Sell |
38,820
-97
| -0.2% | -$158 | ﹤0.01% | 4723 |
|
|
2022
Q3 | $108K | Hold |
38,917
| – | – | ﹤0.01% | 4539 |
|
|
2022
Q2 | $177K | Buy |
38,917
+1,157
| +3% | +$5.08K | ﹤0.01% | 4346 |
|
|
2022
Q1 | $269K | Hold |
37,760
| – | – | ﹤0.01% | 4230 |
|
|
2021
Q4 | $254K | Hold |
37,760
| – | – | ﹤0.01% | 4373 |
|
|
2021
Q3 | $439K | Buy |
37,760
+2,424
| +7% | +$33.5K | ﹤0.01% | 4094 |
|
|
2021
Q2 | $660K | Buy |
35,336
+23,675
| +203% | +$441K | ﹤0.01% | 3809 |
|
|
2021
Q1 | $270K | Buy |
+11,661
| New | +$295K | ﹤0.01% | 4021 |
|
|
2019
Q4 | – | Sell |
-1,479
| Closed | -$22K | – | 4238 |
|
|
2019
Q3 | $22K | Hold |
1,479
| – | – | ﹤0.01% | 4141 |
|
|
2019
Q2 | $36K | Hold |
1,479
| – | – | ﹤0.01% | 4115 |
|
|
2019
Q1 | $53K | Hold |
1,479
| – | – | ﹤0.01% | 4016 |
|
|
2018
Q4 | $53K | Buy |
1,479
+763
| +107% | +$64.3K | ﹤0.01% | 3981 |
|
|
2018
Q3 | $111K | Hold |
716
| – | – | ﹤0.01% | 3907 |
|
|
2018
Q2 | $95K | Buy |
716
+134
| +23% | +$20.3K | ﹤0.01% | 3877 |
|
|
2018
Q1 | $144K | Hold |
582
| – | – | ﹤0.01% | 3772 |
|
|
2017
Q4 | $161K | Hold |
582
| – | – | ﹤0.01% | 3724 |
|
|
2017
Q3 | $235K | Hold |
582
| – | – | ﹤0.01% | 3619 |
|
|
2017
Q2 | $344K | Buy |
582
+38
| +7% | +$22.2K | ﹤0.01% | 3498 |
|
|
2017
Q1 | $334K | Buy |
544
+269
| +98% | +$95.7K | ﹤0.01% | 3473 |
|
|
2016
Q4 | $55K | Hold |
275
| – | – | ﹤0.01% | 3898 |
|
|
2016
Q3 | $72K | Hold |
275
| – | – | ﹤0.01% | 3874 |
|
|
2016
Q2 | $82K | Hold |
275
| – | – | ﹤0.01% | 3844 |
|
|
2016
Q1 | $117 | Hold |
275
| – | – | ﹤0.01% | 3794 |
|
|
2015
Q4 | $136K | Sell |
275
-7
| -2% | -$5.06K | ﹤0.01% | 3799 |
|
|
2015
Q3 | $330K | Buy |
282
+1
| +0.4% | +$1.53K | ﹤0.01% | 3441 |
|
|
2015
Q2 | $496K | Buy |
281
+15
| +6% | +$23.3K | ﹤0.01% | 3204 |
|
|
2015
Q1 | $312K | Hold |
266
| – | – | ﹤0.01% | 3407 |
|
|
2014
Q4 | $266K | Buy |
266
+1
| +0.4% | +$1K | ﹤0.01% | 3471 |
|
|
2014
Q3 | $358K | Hold |
265
| – | – | ﹤0.01% | 3315 |
|
|
2014
Q2 | $448K | Hold |
265
| – | – | ﹤0.01% | 3217 |
|
|
2014
Q1 | $599K | Buy |
265
+79
| +42% | +$202K | ﹤0.01% | 3067 |
|
|
2013
Q4 | $384K | Buy |
186
+111
| +148% | +$240K | ﹤0.01% | 3193 |
|
|
2013
Q3 | $229K | Buy |
+75
| New | +$128K | ﹤0.01% | 3261 |
|
Other funds holding VYNT
Geode Capital Management's VYNT Position: Q2 2023 in Review
Geode Capital Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 38,820 shares — an estimated $22.5K sold.
Geode Capital Management first reported a position in VYNT in Q3 2013 and held it in 34 quarters. The position peaked at $660K in Q2 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.
- Geode Capital Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Geode Capital Management sold 38,820 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $22.5K.
- Geode Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 34 quarters.
- Geode Capital Management's Vyant Bio, Inc. Common Stock position peaked at $660K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.